Atrial Fibrillation After Cardiac Surgery-comparing Conventional and Miniaturized Bypass Systems
Atrial fibrillation (AF) is the most common arrhythmia after cardiac surgery. The incidence of AF varies between 20 - 45 % after (coronary artery bypass grafting) CABG. It may lead to hemodynamic compromise, thromboembolic events, increased length of stay in the hospital and increased morbidity. The underlying cause of AF has been related to a variety of factors. Those most commonly related to the intraoperative management are the use of cardiopulmonary bypass (CPB), the influence of systemic inflammation, myocardial damage, intraoperative fluid management and the need of red blood cell transfusion.
The purpose of the study is to find out the difference in the incidence of atrial fibrillation after CABG when using the conventional (CECC) or mini bypass system (MECC). There has been some evidence in retrospective studies comparing conventional and mini bypass systems that the incidence of AF after mini bypass could be statistically lower.
With the prospective randomized study protocol patient demographic will be similar regarding other variables such as age, gender, previous history of AF, use of beta blockers etc. Only isolated CABG procedures will be included. The amount of patients needed in the study has been calculated so that when the investigators assume that the incidence of AF is normally 45 % and with the mini bypass system the investigators can reduce it to 25 %, the investigators need 330 patients (165 in each group) to show this with the power of 0,8 (a 0,05).
The treatment protocol is similar in both groups except the CPB method (CECC vs. MECC). In both methods the investigators use MAQUET tubing and oxygenator. Fluid management and the use of inotropic agents are standardized and followed by using pulmonary artery catheter. After the operation in the ICU the investigators also use a standardized treatment protocol in the fluid management and in the medication. Patients are ECG-monitored 48 hours after the operation. Possible arrhythmias are documented until the patient is discharged from the hospital.
The investigators also collect special blood samples for determining most relevant factors found affecting in the incidence of AF (IL-6, IL-8, PAI-1).
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
|Official Title:||Atrial Fibrillation After Cardiac Surgery - Prospective, Randomized Study Comparing Conventional and Miniaturized Bypass Systems|
- Atrial fibrillation [ Time Frame: up to 10 days ] [ Designated as safety issue: Yes ]The primary endpoint of this study is the incidence of atrial fibrillation
|Study Start Date:||July 2010|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
Miniaturized bypass system
Miniaturized bypass system and the incidence of atrial fibrillation after cardiac surgery
Procedure: Miniaturized bypass system
Compare the conventional bypass system and miniaturized bypass system of the incidence of atrial fibrillation after cardiac surgery
Other Name: Miniaturized extracorporeal circulation
Please refer to this study by its ClinicalTrials.gov identifier: NCT01160393
|Contact: Pekka Korvenoja, MD||+35817 email@example.com|
|Kuopio University Hospital||Recruiting|
|Kuopio, Finland, 70211|
|Contact: Pekka Korvenoja, MD +35817 173311 firstname.lastname@example.org|
|Sub-Investigator: Sten Ellam, MD|
|Sub-Investigator: Otto Pitkänen, MD,PhD|
|Sub-Investigator: Esko Tyrväinen, MD|
|Sub-Investigator: Jari Halonen, MD|
|Sub-Investigator: Antti Valtola, MD|
|Sub-Investigator: Vesa Kiviniemi|
|Sub-Investigator: Juha Hartikainen, MD, PhD|
|Principal Investigator:||Pekka Korvenoja, MD||Cardiac anesthesiologist, KuopioUH|